Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions (STANCE)

This study has been completed.
Information provided by (Responsible Party):
480 Biomedical, Inc. Identifier:
First received: July 25, 2011
Last updated: February 9, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)